MeiraGTx Holdings (MGTX) Assets Average (2017 - 2025)
MeiraGTx Holdings (MGTX) posted Assets Average of $217.0 million for Q4 2025, up 11.78% on a QoQ basis from $194.1 million in Q3 2025, and down 23.78% year-over-year from $284.6 million in Q4 2024.
MeiraGTx Holdings (MGTX) Assets Average (2017 - 2025) Analysis & Trends
MeiraGTx Holdings' Assets Average history runs 9 years deep, the most recent figure standing at $217.0 million for Q4 2025.
- Quarterly Assets Average fell 23.78% year-over-year to $217.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $217.0 million (down 23.78% YoY) and the FY2025 annual result came in at $257.1 million, down 13.8% from the prior year.
- Assets Average was $217.0 million for Q4 2025 at MeiraGTx Holdings, up from $194.1 million in the prior quarter.
- Across five years, Assets Average topped out at $318.0 million in Q1 2024 and bottomed at $1.7 million in Q1 2021.
- A 5-year average of $157.5 million and a median of $163.6 million in 2022 frame the typical range for Assets Average.
- Annual changes were most pronounced in 2021 — Assets Average jumped 11449.38% — and 2023, when it slumped 65.44%.
- MeiraGTx Holdings' Assets Average stood at $162.1 million in 2021, then climbed by 0.51% to $162.9 million in 2022, then surged by 82.28% to $297.0 million in 2023, then decreased by 4.16% to $284.6 million in 2024, then declined by 23.78% to $217.0 million in 2025.
- Business Quant data shows MGTX's Assets Average at $217.0 million in Q4 2025, $194.1 million in Q3 2025, and $211.4 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 303.40 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 65.01 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 8.37 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 41.64 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 26.06 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 40.71 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 795.91 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.30 Bn |
| 10 | MeiraGTx Holdings | 973.21 Mn | 907.27 Mn | - | 216.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 216.95 Mn |
| Sep 30, 2025 | 194.09 Mn |
| Jun 30, 2025 | 211.37 Mn |
| Mar 31, 2025 | 246.88 Mn |
| Dec 31, 2024 | 284.62 Mn |
| Sep 30, 2024 | 283.07 Mn |
| Jun 30, 2024 | 287.94 Mn |
| Mar 31, 2024 | 317.99 Mn |
| Dec 31, 2023 | 296.97 Mn |
| Sep 30, 2023 | 134.79 Mn |
| Jun 30, 2023 | 2.77 Mn |
| Mar 31, 2023 | 160.70 Mn |
| Dec 31, 2022 | 162.92 Mn |
| Sep 30, 2022 | 7.54 Mn |
| Jun 30, 2022 | 8.03 Mn |
| Mar 31, 2022 | 164.37 Mn |
| Dec 31, 2021 | 162.10 Mn |
| Sep 30, 2021 | 3.61 Mn |
| Jun 30, 2021 | 2.45 Mn |
| Mar 31, 2021 | 1.66 Mn |